Poor Investigation Follow Up Lands Drugmaker a 483

Drug GMP Report
A A
Stason Pharmaceuticals received a Form 483 for not properly following up on deviations and storing equipment in a “haphazard manner.”

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $135.00